FDA Adverse Event Injury Summary report: N

ENDOVIVE INITIAL PLACEMENT PEG KIT, DIRECT PEJ KIT, AND PEG SAFETY KIT

MDR report key: 2044369 · Received April 7, 2011

Report

Report Number
3005099803-2011-01093
Event Type
Injury
Date Received
April 7, 2011
Date of Event
March 9, 2011
Report Date
March 16, 2011
Manufacturer
BOSTON SCIENTIFIC - SPENCER
Product Code
KNT
PMA / PMN Number
K031538
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4):THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ENDOVIVE STANDARD PULL METHOD KIT WAS BEING USED IN CONJUNCTION WITH A J-TUBE FOR THE PURPOSE OF ADMINISTERING MEDICATION FOR THE ADVANCED STAGE OF PARKINSON'S DISEASE. THE PATIENT HAS BEEN USING BOSTON SCIENTIFIC PEG/J-TUBES SINCE 2009. ACCORDING TO THE COMPLAINANT, THE PATIENT HAS HAD REPEATED INFECTION PROBLEMS. APPROXIMATELY AROUND (B)(6), 2011 THE INTERNAL BOLSTER WAS BURIED IN THE STOMACH WALL MUCOSA AND THE PATIENT PRESENTED WITH AN INFECTION. THE PEG/J-TUBE WAS REMOVED. WHEN THE STOMA HAS HEALED A NEW PEG/J-TUBE WILL BE PLACED (THE MANUFACTURER IS UNKNOWN AT THIS TIME). THE PATIENT WAS NOT HOSPITALIZED DUE TO THIS EVENT. THE PATIENT RECEIVED A NASOINTESTINAL TUBE SO THAT THE DUODOPA TREATMENT COULD CONTINUE. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ENDOVIVE STANDARD PULL METHOD KIT WAS BEING USED IN CONJUNCTION WITH A J-TUBE FOR THE PURPOSE OF ADMINISTERING MEDICATION FOR THE ADVANCED STAGE OF PARKINSON'S DISEASE. THE PATIENT HAS BEEN USING BOSTON SCIENTIFIC PEG/J-TUBES SINCE 2009. ACCORDING TO THE COMPLAINANT, THE PATIENT HAS HAD REPEATED INFECTION PROBLEMS. APPROXIMATELY AROUND (B)(6), 2011 THE INTERNAL BOLSTER WAS BURIED IN THE STOMACH WALL MUCOSA AND THE PATIENT PRESENTED WITH AN INFECTION. THE PEG/J-TUBE WAS REMOVED. WHEN THE STOMA HAS HEALED A NEW PEG/J-TUBE WILL BE PLACED (THE MANUFACTURER IS UNKNOWN AT THIS TIME). THE PATIENT WAS NOT HOSPITALIZED DUE TO THIS EVENT. THE PATIENT RECEIVED A NASOINTESTINAL TUBE SO THAT THE DUODOPA TREATMENT COULD CONTINUE. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOVIVE INITIAL PLACEMENT PEG KIT, DIRECT PEJ KIT, AND PEG SAFETY KIT TUBES, GASTROINTESTINAL (AND ACCESSORIES) KNT BOSTON SCIENTIFIC - SPENCER M00568381 12471972

Patients

Seq Age Sex Outcome Treatment
1 67 YR Other DUODOPA